International Clinical Trials Day provided the chance to recognise the many people contributing to our life-changing clinical trials. Two key events were staged to mark the day, including a presentation in the Kolling auditorium from leading clinical trial investigators, and a public display within Royal North Shore Hospital.  More than 300 trials are underway across Northern Sydney including .....
Read more

Check out our latest newsletter Researchers target sleep for muscle pain relief Landmark clinical trial to improve lung cancer treatment Pioneering Muscle Map project receives funding support Travel awards for emerging research leaders And much more:  Click here:
Read more

Five emerging researchers will have the chance to develop their skills and raise the international profile of the Kolling Institute thanks to generous funding from the Skipper Jacobs Charitable Trust. Academic Director Professor James Elliott said a total of $40,000 will be shared by the early-to-mid career researchers to increase their research impact and strengthen their collaborations. Pablo Cru.....
Read more

For the past 20 years, Professor Sarah Hilmer has dedicated her career to optimising medicine use for older people and has achieved recognition as a national and world leader in geriatric pharmacology. Not only has the Royal North Shore Hospital clinical pharmacologist and geriatrician set about improving medication practices for older people, but she has long advocated for ‘age-friendly’ clinical .....
Read more

Two emerging leaders within the Kolling Institute’s Ageing and Pharmacology Lab are gaining attention for their impressive work to improve the quality use of medications. Dr Nashwa Masnoon and Dr Kenji Fujita have received prestigious awards at the annual meeting of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT). Nashwa, who is also a pharmacist at .....
Read more

The Kolling Institute’s Professor Sue Kurrle and her team at the Rehabilitation and Aged Care Network at Hornsby Ku-ring-gai Hospital have been running clinical trials for 25 years, looking at dementia, frailty, and falls to name just some areas. “We do trials as it keeps you cutting edge and they are really important for our patients,” she says. As a geriatrician on the frontline, Sue is well posi.....
Read more

A $3-million research grant will help develop technology to identify frailty in older people in hospital, a crucial step towards improving care and long-term patient outcomes. The Kolling Institute’s Professor Sarah Hilmer will lead the large-scale study involving hospitals and universities across Australia as well as international investigators. Professor Hilmer said the five-year project will dev.....
Read more

We would like to thank everyone involved in the 2024 Kolling Institute Symposium. During the event, a diverse collection of researchers detailed the latest progress with their ground-breaking work into kidney and heart disease treatments, bone and muscle conditions, rare cancers, and neurological challenges. There was a focus too on the innovative work to develop a unique wellbeing index. Researche.....
Read more

Our Kolling Institute newsletter brings together a collection of profiles on our impressive researchers. Flip through our flipping book to discover more about our leading research into kidney disease, rare cancers and the use of supplements for osteoarthritis. There's a focus too on the first steps towards gene therapy for Meniere's disease, the latest research into treatments for dementia and.....
Read more

In the heart of the Kolling Institute, a world-renowned research centre, a raft of clinical trials is driving the future of healthcare. “Clinical trials are intrinsic to research,” says Professor James Elliott, Academic Director of the institute. “They help us test something so that we can better inform care for patients with various conditions who come to our hospitals for treatment.” The Kolling .....
Read more